TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 110 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $288,000 | -18.6% | 4,330 | -25.2% | 0.02% | -31.8% |
| Q1 2020 | $354,000 | -38.2% | 5,785 | -11.2% | 0.02% | 0.0% |
| Q4 2019 | $573,000 | +5.9% | 6,515 | -9.2% | 0.02% | -8.3% |
| Q3 2019 | $541,000 | -26.7% | 7,175 | -16.9% | 0.02% | -17.2% |
| Q2 2019 | $738,000 | -45.1% | 8,635 | -30.6% | 0.03% | -37.0% |
| Q1 2019 | $1,344,000 | +26.1% | 12,435 | -1.3% | 0.05% | +39.4% |
| Q4 2018 | $1,066,000 | -7.9% | 12,600 | +7.0% | 0.03% | +17.9% |
| Q3 2018 | $1,157,000 | -15.5% | 11,775 | -0.5% | 0.03% | -15.2% |
| Q2 2018 | $1,369,000 | -1.3% | 11,830 | -15.8% | 0.03% | +6.5% |
| Q1 2018 | $1,387,000 | – | 14,045 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |